New User:
-or-
Username:
Password:
Forgot your password?
News Breaks
06:24 EDT
CYPB
theflyonthewall.com:
Cypress Bioscience upgraded to Outperform from Perform at Oppenheimer
Oppenheimer upgraded Cypress Bioscience on valuation following the recent weakness in shares. Target $9.
:theflyonthewall.com
News For CYPB From The Last 14 Days
Check below for free stories on CYPB the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for these search parameters.
